PTP1B is highly validated as a therapeutic target for diabetes (Elchebly et al., 1999) and cancer (Krishnan et al., 2014) and has also been linked to Rett syndrome (Krishnan et al., 2015). This evidence concerns the gene PTPN1 and diabetes mellitus.